Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice

European Neuropsychopharmacology

Volumn 8, Issue 2, 1998, Pages 95-103

  Rodriguez Arias M ^a   Minarro J ^a   Aguilar, M A ^a   Pinazo, J ^a   Simon V M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Aggression; Mice; Motor activity; Risperidone; SCH 23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; RISPERIDONE; SODIUM CHLORIDE; TARTARIC ACID;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; EXPLORATORY BEHAVIOR; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOCIAL ISOLATION; THREAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AGGRESSION; ANIMALS; DEPRESSION, CHEMICAL; DOPAMINE ANTAGONISTS; EXPLORATORY BEHAVIOR; FEMALE; GROOMING; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RISPERIDONE; SEXUAL BEHAVIOR, ANIMAL; SOCIAL ISOLATION;

EID: 0345267228     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00051-5     Document Type: Article

References (45)

1. Acquas E., Carboni E., Leone P., DiChiara G. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology. 99:1989;151-155.
2. 1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav. Pharmacol. 5:1994;555-569.
3. Aguilar M.A., Rodriguéz-Arias M., Miñarro J., Simón V.M. Time course of the effects of haloperidol on agonistic behaviour in male mice. Psicothema. 6(2):1994;191-196.
4. Aguilar M.A., Miñarro J., Pérez-Iranzo N., Simón V.M. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol. Biochem. Behav. 47(3):1994;753-756.
5. Arregui A., Axpiroz A., Brain P.F., Simon V. Effects of two selective dopaminergic antagonists on ethologically-assessed encounters in male mice. Gen. Pharmacol. 24:1993;353-356.
6. Benus R.F., Bohus B., Koolhaas J.M., Van-Oortmerssen G.A. Behavioural differences between artificially selected aggressive and non-aggressive mice: Response to apomorphine. Behav. Brain Res. 43(2):1991;203-208.
7. Borrás-Valls J.J., Salvador A., Simón V.M. Acute and chronic effects of clomipramine on isolation-induced aggression in male mice. Psychobiology. 22(3):1994;226-231.
8. Brain, P.F., McAllister, K.H., Wamsley, S.V., 1989. Drug effects on social behavior. Methods in ethopharmacology. In: Boulton, A.A., Baker, G.B., Greeshaw, A.J. (Eds.), Neuromethods, Vol. 13. The Human Press, Clifton, NJ, pp. 687-739.
9. Corbett R., Hartman H., Kerman L.L., Woods A.T., Strupczewski J.T., Helsley G.C., Conway P.G., Dunn R.W. Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol. Biochem. Behav. 45:1993;9-17.
10. 2 (raclopride) antagonists. Psychopharmacology. 115:1994;24-30.
11. Garmendia L., Sánchez J.R., Azpiroz A., Brain P.F., Simón V. Clozapine: strong antiaggressive effects with minimal motor impairment. Physiol. Behav. 51:1991;51-54.
12. Glennon R.A. Central serotonin receptors as targets for drug research. J. Med. Chem. 30:1987;1-12.
13. 1 dopamine receptor antagonist, SCH 23390, reduces locomotor activity and rearing in rats. Pharmacol. Biochem. Behav. 22:1985;341-342.
14. 1 antagonist. Eur. J. Pharmacol. 91:1983;153-154.
15. Iorio L.C., Barnett A., Leitz F.H., Houser V.P., Kordoba C.A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226:1983;462-468.
16. Ison M., Fachinelli C., Rodríguez Echandía E.L. Effect of the injection of 5,7-di-hydroxytryptamine on the aggressive behavior of dominant and submissive pigeons (Columba livia). Pharmacol. Biochem. Behav. 53(4):1996;951-955.
17. Kakigi T., Gao X.M., Tamminga C.A. Drug-induced oral dyskinesias in rats after traditional and new neuroleptics. J. Neural Transm. 101:1995;41-49.
18. Kinon B.J., Lieberman J.A. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology. 124:1996;2-34.
19. Lappalainen J., Hietala J., Syvälahti E. Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration. Psychopharmacology. 98:1989;472-475.
20. Martin M., Caño A., Navarro J.F. Efectos de la administración de dosis altas de sulpiride sobre la conducta agonística en ratones macho. Psicothema. 8(1):1996;161-168.
21. Martinez M., Castaño D., Simón V.M., Brain P.F. An ethopharmacological assessment of the influences of cyproterone acetate on social interactions in male mice. IRCS Med. Sci. 14:1986;44-45.
22. Martinez M., Miñarro J., Simón V.M. Análisis etoexperimental de la conducta agonística en ratones. Psicológica. 12:1991;1-22.
23. McMillen B.A., DaVanzo E.A., Song A.H., Scott S.M., Rodríguez M.E. Effects of classical atypical antipsychotic drugs on isolation-induced aggression in male mice. Eur. J. Pharmacol. 160:1989;149-153.
24. Megens A.A.H.P., Niemegeers C.J.E., Awouters F.H.L. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol. J. Pharmacol. Exp. Ther. 260(1):1992;160-167.
25. i values. J. Pharmacol. Exp. Ther. 251:1989;238-246.
26. Meltzer H.Y., Lee M.A., Ranjan R. Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatr. Scand. 90(suppl 384):1994;95-101.
27. Meltzer, H.Y., 1995. Atypical antipsychotic drugs. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York. pp. 108, 1277-1286.
28. Mesotten F.S., Pictquin E., Burton P., Heylen S., Gelders Y. Therapeutic effect and safety of increasing doses of risperidone (R 64 766) in psychotic patients. Psychopharmacology. 99:1989;445-449.
29. Miñarro J., Castaño D., Brain P.F., Simón V.M. Haloperidol does not antagonize the effects of stress on aggressive behaviour in mice. Physiol. Behav. 47:1990;281-285.
30. 2 dopamine receptor agonists, and the influence of selective antagonists. Pharmacol. Biochem. Behav. 25:1986;249-253.
31. Muehlenkamp F., Lucion A., Vogel W.H. Effects of selective serotoninergic agonists on aggressive behavior in rats. Pharmacol. Biochem. Behav. 50(4):1995;671-674.
32. Olivier B., Mos J., Van Orrschot R. Maternal aggression in rats: lack of interaction between clordiazepoxide and fluprazine. Psychopharmacology. 88:1986;40-43.
33. Olivier B., Mos J., Heyden J., Hartog J. Serotonergic modulation of social interactions in isolated male mice. Psychopharmacology. 97:1989;154-156.
34. Perry P.J. Clinical use of a newer antipsychotic drug. Am. J. Health-Syst. Pharm. 52(1):1995;S9-S14.
35. Pickar D. Prospects for pharmacotherapy of schizophrenia. Lancet. 345(8949):1995;557-562.
36. 2 agonist RU 24213. Psychopharmacology. 87:1985;308-312.
37. Redolat R., Brain P.F., Simón V.M. Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity. Neuropharmacology. 30:1991;41-46.
38. Rodríguez-Arias M., Miñarro J. Efectos de la morfina y el haloperidol sobre la conducta agonística en ratones macho. Psicothema. 8(2):1996;351-358.
39. Rodríguez-Arias, M., Miñarro, J., Simón, V.M. (in press) Interaction of morphine and haloperidol on agonistic behavior in male mice. Pharmacol. Biochem. Behav.
40. Sánchez C., Arnt J., Hyttel J., Moltzen E.K. The role of serotoninergic mechanisms in inhibition of isolation-induced aggression in male mice. Psychopharmacology. 110:1993;53-59.
41. 2 dopamine receptor blockade. J. Pharmacol. Exp. Ther. 253:1990;1162-1170.
42. Schotte A., Janssen P.F.M., Gommeren W., Luyten W.H.M.L., Van Gompel P., Lesage A.S., De Loore K., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124:1996;57-63.
43. Smoothy R., Brain P.F., Berry M.S., Haug M. Alcohol and social behaviour in group housed female mice. Physiol. Behav. 37:1986;689-694.
44. Ushijima I., Mizuki Y., Yamada M. Development of tolerance and reverse tolerance to haloperidol and SCH 23390-induced cataleptic effects during withdrawal periods after long-term treatment. Pharmacol. Biochem. Behav. 50:1995;259-264.
45. White S.M., Kucharik R.F., Moyer J.A. Effects of serotoninergic agents on isolation-induced aggression. Pharmacol. Biochem. Behav. 39:1991;729-736.